Lipocine Inc.
LPCN
$7.67
$0.385.21%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -232.99% | -43.63% | 28.12% | -153.08% | 178.09% |
| Total Depreciation and Amortization | -3.85% | 65.88% | 89.41% | 83.53% | 95.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 41.99% | 109.73% | 420.83% | 116.95% | 89.61% |
| Change in Net Operating Assets | -656.87% | 139.50% | -52.33% | 87.23% | -115.35% |
| Cash from Operations | -271.54% | -5.39% | 24.49% | -181.80% | 184.16% |
| Capital Expenditure | -- | -- | -- | -- | -8.70% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 103.83% | -36.38% | -5.31% | 78.43% | -71.81% |
| Cash from Investing | 106.50% | -31.40% | -5.31% | 78.43% | -72.09% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -63.88% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -65.23% | -- | 100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -47.02% | -18.37% | 8.79% | -68.68% | 252.31% |